Net profit of Thyrocare Technologies rose 41.11% to Rs 17.78 crore in the quarter ended March 2024 as against Rs 12.60 crore during the previous quarter ended March 2023. Sales rose 13.52% to Rs 154.25 crore in the quarter ended March 2024 as against Rs 135.88 crore during the previous quarter ended March 2023.For the full year,net profit rose 9.72% to Rs 70.76 crore in the year ended March 2024 as against Rs 64.49 crore during the previous year ended March 2023. Sales rose 8.58% to Rs 571.88 crore in the year ended March 2024 as against Rs 526.67 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales154.25135.88 14 571.88526.67 9 OPM %21.7818.17 -24.0322.79 - PBDT35.9628.04 28 142.99127.30 12 PBT22.9017.24 33 95.9888.59 8 NP17.7812.60 41 70.7664.49 10 Powered by Capital Market - Live News

Thyrocare Technologies announced that the Board of Directors of the Company at its meeting held on 14 May 2024, has recommended a Final dividend of Rs.18 per share (i.e.180%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 14 May 2024Powered by Capital Market - Live News

Thyrocare Technologies has appointed Nitin Chugh has been appointed as Chief Commercial Officer of the Company, being part of the Senior Management of the Company w.e.f. 22 February 2024. Powered by Capital Market - Live News

Net profit of Thyrocare Technologies rose 4.28% to Rs 15.35 crore in the quarter ended December 2023 as against Rs 14.72 crore during the previous quarter ended December 2022. Sales rose 5.24% to Rs 134.74 crore in the quarter ended December 2023 as against Rs 128.03 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales134.74128.03 5 OPM %23.4521.76 - PBDT33.3829.87 12 PBT19.9119.72 1 NP15.3514.72 4 Powered by Capital Market - Live News